- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-7838
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Dalbavancin: novel candidate for COVID-19 treatment ; volume:31 ; number:3 ; day:20 ; month:1 ; year:2021 ; pages:243-244 ; date:3.2021
Cell research ; 31, Heft 3 (20.1.2021), 243-244, 3.2021
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41422-020-00459-5
- URN
-
urn:nbn:de:101:1-2022111909073148086079
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hoffmann, Markus
- Jin, Yeonhwa
- Pöhlmann, Stefan
- SpringerLink (Online service)
Other Objects (12)
Publisher Correction: Dalbavancin: novel candidate for COVID-19 treatment
Erythropoietin as candidate for supportive treatment of severe COVID-19
Novel Strategies for the Treatment of COVID-19
Discovery of novel non-peptidic and non-covalent small-molecule 3CLpro inhibitors as potential candidate for COVID-19 treatment
A promising vaccine candidate against COVID-19
Correction: Discovery of novel non-peptidic and non-covalent small-molecule 3CLpro inhibitors as potential candidate for COVID-19 treatment
Identification of novel candidate genes involved in individual antidepressant treatment response
Synthesis of Remdesivir (GS-5734) — A Candidate for the Treatment of Ebola and COVID-19 Infections
SIT1 transporter as a potential novel target in treatment of COVID-19
Single candidate optimizer: a novel optimization algorithm
Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
Cancer research, treatment, and COVID-19
Publisher Correction: Dalbavancin: novel candidate for COVID-19 treatment
Erythropoietin as candidate for supportive treatment of severe COVID-19
Novel Strategies for the Treatment of COVID-19
Discovery of novel non-peptidic and non-covalent small-molecule 3CLpro inhibitors as potential candidate for COVID-19 treatment
A promising vaccine candidate against COVID-19
Correction: Discovery of novel non-peptidic and non-covalent small-molecule 3CLpro inhibitors as potential candidate for COVID-19 treatment
Identification of novel candidate genes involved in individual antidepressant treatment response
Synthesis of Remdesivir (GS-5734) — A Candidate for the Treatment of Ebola and COVID-19 Infections
SIT1 transporter as a potential novel target in treatment of COVID-19
Single candidate optimizer: a novel optimization algorithm
Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
Cancer research, treatment, and COVID-19
Publisher Correction: Dalbavancin: novel candidate for COVID-19 treatment
Erythropoietin as candidate for supportive treatment of severe COVID-19
Novel Strategies for the Treatment of COVID-19
Discovery of novel non-peptidic and non-covalent small-molecule 3CLpro inhibitors as potential candidate for COVID-19 treatment
A promising vaccine candidate against COVID-19
Correction: Discovery of novel non-peptidic and non-covalent small-molecule 3CLpro inhibitors as potential candidate for COVID-19 treatment
Identification of novel candidate genes involved in individual antidepressant treatment response
Synthesis of Remdesivir (GS-5734) — A Candidate for the Treatment of Ebola and COVID-19 Infections
SIT1 transporter as a potential novel target in treatment of COVID-19
Single candidate optimizer: a novel optimization algorithm
Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19